C K Kasper|L Parton - JoVE Visualize

Showing results (101-110 of 113) with videos related to

Pageof 12

Sort By:

Transfusion|November 1, 1985

Evaluation of two viral inactivation methods for the preparation of safer factor VIII and factor IX concentratesC M Heldebrant, E D Gomperts, C K Kasper, et al.

Blood|December 1, 1986

The heterogeneity of type IIA von Willebrand's disease: studies with protease inhibitorsJ Batlle, M F Lopez Fernandez, M Campos, et al.

Thrombosis and Haemostasis|September 1, 1995

Comparison of six commercial plasma references for factor VIII, factor IX and von Willebrand factor. On behalf of the Subcommittee for Factor VIII and IX of the Scientific and Standardization Committee of the ISTHC K Kasper, D L Aronson, G Davignon, et al.

Blood|December 1, 1985

Long-term follow-up of hemophiliacs with lymphocytopenia or thrombocytopeniaM E Eyster, D A Whitehurst, P M Catalano, et al.

Annals of Internal Medicine|June 1, 1988

Primary pulmonary hypertension in patients with classic hemophiliaG H Goldsmith, R G Baily, D B Brettler, et al.

Biochemistry|July 14, 2018

An Open Library of Human Kinase Domain Constructs for Automated Bacterial ExpressionSteven K Albanese, Daniel L Parton, Mehtap Işık, et al.

Thrombosis and Haemostasis|January 1, 1996

Safety profile of porcine factor VIII and its use as hospital and home-therapy for patients with haemophilia-A and inhibitors: the results of an international surveyC R Hay, J N Lozier, C A Lee, et al.

Journal of Perinatology : Official Journal of the California Perinatal Association|July 6, 2000

Long-term follow-up of premature infants treated with prophylactic, intratracheal recombinant human CuZn superoxide dismutaseJ M Davis, S E Richter, S Biswas, et al.

Human Genetics|January 27, 2000

Germline origins in the human F9 gene: frequent G:C-->A:T mosaicism and increased mutations with advanced maternal ageR P Ketterling, E Vielhaber, X Li, et al.

Thrombosis and Haemostasis|May 6, 1998

Factor VIII inhibitors in mild and moderate-severity haemophilia A. UK Haemophilia Centre Directors OrganisationC R Hay, C A Ludlam, B T Colvin, et al.

Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:

Pageof 12

Transfusion|November 1, 1985

Evaluation of two viral inactivation methods for the preparation of safer factor VIII and factor IX concentratesC M Heldebrant, E D Gomperts, C K Kasper, et al.

Blood|December 1, 1986

The heterogeneity of type IIA von Willebrand's disease: studies with protease inhibitorsJ Batlle, M F Lopez Fernandez, M Campos, et al.

Thrombosis and Haemostasis|September 1, 1995

Comparison of six commercial plasma references for factor VIII, factor IX and von Willebrand factor. On behalf of the Subcommittee for Factor VIII and IX of the Scientific and Standardization Committee of the ISTHC K Kasper, D L Aronson, G Davignon, et al.

Blood|December 1, 1985

Long-term follow-up of hemophiliacs with lymphocytopenia or thrombocytopeniaM E Eyster, D A Whitehurst, P M Catalano, et al.

Annals of Internal Medicine|June 1, 1988

Primary pulmonary hypertension in patients with classic hemophiliaG H Goldsmith, R G Baily, D B Brettler, et al.

Biochemistry|July 14, 2018

An Open Library of Human Kinase Domain Constructs for Automated Bacterial ExpressionSteven K Albanese, Daniel L Parton, Mehtap Işık, et al.

Thrombosis and Haemostasis|January 1, 1996

Safety profile of porcine factor VIII and its use as hospital and home-therapy for patients with haemophilia-A and inhibitors: the results of an international surveyC R Hay, J N Lozier, C A Lee, et al.

Journal of Perinatology : Official Journal of the California Perinatal Association|July 6, 2000

Long-term follow-up of premature infants treated with prophylactic, intratracheal recombinant human CuZn superoxide dismutaseJ M Davis, S E Richter, S Biswas, et al.

Human Genetics|January 27, 2000

Germline origins in the human F9 gene: frequent G:C-->A:T mosaicism and increased mutations with advanced maternal ageR P Ketterling, E Vielhaber, X Li, et al.

Thrombosis and Haemostasis|May 6, 1998

Factor VIII inhibitors in mild and moderate-severity haemophilia A. UK Haemophilia Centre Directors OrganisationC R Hay, C A Ludlam, B T Colvin, et al.

Pageof 12